Alector Inc (ALEC) Stock Analysis

Alector Inc (ALEC) is a publicly traded company in the HEALTHCARE sector. It trades at $1.95, carries a market capitalization of $229.82M. This page summarizes the public market data, fundamentals, and frequently asked questions for ALEC, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Alector Inc currently has a Bearish sentiment score of -0.20.

About Alector Inc

Alector, Inc. (ALEC) is a pioneering clinical-stage biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative conditions, including Alzheimer's disease and frontotemporal dementia. Utilizing its proprietary immuno-neurology platform, Alector aims to leverage the immune system to rejuvenate neuronal health and functionality. Based in South San Francisco, California, the company is at the forefront of research and development aimed at transforming treatment pa...

GNG Research Analysis

GNG Research scores Alector Inc (ALEC) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ALEC.

Frequently Asked Questions

Does ALEC pay dividends?

Alector Inc (ALEC) does not currently pay a regular dividend.

What is ALEC's market cap?

Alector Inc (ALEC) has a market capitalization of $229.82M with a current stock price of $1.95.